Pyrrolidine Melanocortin-Specific Compounds
    21.
    发明申请
    Pyrrolidine Melanocortin-Specific Compounds 有权
    吡咯烷黑皮质素特异性化合物

    公开(公告)号:US20070155670A1

    公开(公告)日:2007-07-05

    申请号:US11680932

    申请日:2007-03-01

    IPC分类号: A61K38/04 C07K5/06

    摘要: Melanocortin receptor-specific pyrrolidine compounds having the structure: and stereoisomer and pharmaceutically acceptable salts thereof, where R1, R2, and R3 are as described in the specification, preferably where R3 is a D-amino acid with at least one substituted or unsubstituted phenyl or naphthyl aromatic ring, and where R3 optionally further includes an amine capping group or from one to three additional amino acid residues, optionally with an amine capping group, which compounds are agonists, antagonists or mixed agonists and antagonists at one or more melanocortin receptors, and having utility in the treatment of melanocortin receptor-related disorders and conditions. Methods of synthesis of compounds of structure (I), pharmaceutical compositions containing a compound of structure (I) and methods relating to the use thereof are also disclosed.

    摘要翻译: 具有以下结构的黑皮质素受体特异性吡咯烷化合物及其立体异构体和药学上可接受的盐,其中R 1,R 2和R 3是 如说明书中所述,优选其中R 3是具有至少一个取代或未取代的苯基或萘基芳环的D-氨基酸,并且其中R 3'任选地进一步包括 胺封端基团或一至三个另外的氨基酸残基,任选具有胺封端基团,该化合物是一种或多种黑皮质素受体的激动剂,拮抗剂或混合激动剂和拮抗剂,并且可用于治疗黑皮质素受体相关 疾病和病症。 还公开了结构(I)化合物的合成方法,含有结构(I)化合物的药物组合物及其使用方法。

    Compounds and Methods for Treating Obesity
    24.
    发明申请
    Compounds and Methods for Treating Obesity 审中-公开
    化合物和治疗肥胖症的方法

    公开(公告)号:US20090076029A1

    公开(公告)日:2009-03-19

    申请号:US12130316

    申请日:2008-05-30

    IPC分类号: A61K31/496 G01N33/53 A61P3/04

    摘要: Methods for selection of compounds for treatment of obesity, compounds selected by the disclosed methods, and methods of treatment of obesity, wherein a selective melanocortin-4 receptor compound is identified, which compound is further characterized in that it attenuates the binding of both an agonist, including alpha-melanocyte stimulating hormone, and an inverse agonist, including agouti-related protein, to a melanocortin receptor, including melanocortin-4 receptor.

    摘要翻译: 用于选择用于治疗肥胖症的化合物的方法,通过公开的方法选择的化合物和治疗肥胖症的方法,其中鉴定了选择性黑皮质素-4受体化合物,该化合物的特征还在于其减弱激动剂 ,包括α-黑素细胞刺激激素和包括agouti相关蛋白的反向激动剂,包括黑皮质素受体,包括黑皮质素-4受体。

    Metallopeptide compounds
    27.
    发明申请
    Metallopeptide compounds 有权
    金属肽化合物

    公开(公告)号:US20050282739A1

    公开(公告)日:2005-12-22

    申请号:US11188552

    申请日:2005-07-25

    摘要: Metallopeptides with a sequence of a biologically active alpha-melanocyte stimulating hormone (α-MSH), gamma-melanocyte stimulating hormone (γ-MSH), or bombesin sequence of length n residues, wherein a residue including a nitrogen atom and sulfur atom each available for complexation to a metal ion is inserted at any position from between the two and three position to the C-terminus side of the n position, or alternatively is substituted for the residue at any position from the three position to the n position, with a metal ion complexed thereto, with any proline (Pro) residue which is either of the two residues on the immediately adjacent N-terminus side of the inserted or substituent residue comprising a nitrogen atom and sulfur atom available for complexation to a metal ion is substituted with a homolog.

    摘要翻译: 具有生物活性α-黑素细胞刺激激素(α-MSH),γ-黑素细胞刺激激素(γ-MSH)或长度为n个残基的铃蟾肽序列的序列的金属肽,其中包含氮原子和硫原子的残基各自可用 用于与金属离子的络合被插入到位于n位置的两个和三个位置到C末端侧的任何位置处,或者替代地在从三个位置到n个位置的任何位置处的残基代替, 金属离子与其中包含可与金属离子络合的氮原子和硫原子的插入或取代残基的直接相邻的N末端侧的两个残基中的任一种的脯氨酸(Pro)残基取代, 同系物